nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—Cyst—Varenicline—nicotine dependence	0.0445	0.0455	CcSEcCtD
Thiotepa—Intestinal obstruction—Varenicline—nicotine dependence	0.0437	0.0447	CcSEcCtD
Thiotepa—Extrapyramidal disorder—Varenicline—nicotine dependence	0.0395	0.0404	CcSEcCtD
Thiotepa—Endocrine disorder—Varenicline—nicotine dependence	0.0359	0.0367	CcSEcCtD
Thiotepa—Photophobia—Varenicline—nicotine dependence	0.0279	0.0286	CcSEcCtD
Thiotepa—Oesophagitis—Varenicline—nicotine dependence	0.0272	0.0278	CcSEcCtD
Thiotepa—Deafness—Varenicline—nicotine dependence	0.0242	0.0247	CcSEcCtD
Thiotepa—Urinary retention—Varenicline—nicotine dependence	0.0205	0.021	CcSEcCtD
Thiotepa—Weight increased—Varenicline—nicotine dependence	0.017	0.0174	CcSEcCtD
Thiotepa—Hyperglycaemia—Varenicline—nicotine dependence	0.0168	0.0172	CcSEcCtD
Thiotepa—Infestation NOS—Varenicline—nicotine dependence	0.0167	0.017	CcSEcCtD
Thiotepa—Infestation—Varenicline—nicotine dependence	0.0167	0.017	CcSEcCtD
Thiotepa—Stomatitis—Varenicline—nicotine dependence	0.0162	0.0166	CcSEcCtD
Thiotepa—Conjunctivitis—Varenicline—nicotine dependence	0.0162	0.0166	CcSEcCtD
Thiotepa—Hepatobiliary disease—Varenicline—nicotine dependence	0.0157	0.0161	CcSEcCtD
Thiotepa—Epistaxis—Varenicline—nicotine dependence	0.0157	0.0161	CcSEcCtD
Thiotepa—Hallucination—Varenicline—nicotine dependence	0.0149	0.0152	CcSEcCtD
Thiotepa—Urinary tract disorder—Varenicline—nicotine dependence	0.0148	0.0151	CcSEcCtD
Thiotepa—Connective tissue disorder—Varenicline—nicotine dependence	0.0147	0.015	CcSEcCtD
Thiotepa—Urethral disorder—Varenicline—nicotine dependence	0.0147	0.015	CcSEcCtD
Thiotepa—Eye disorder—Varenicline—nicotine dependence	0.014	0.0143	CcSEcCtD
Thiotepa—Tinnitus—Varenicline—nicotine dependence	0.0139	0.0143	CcSEcCtD
Thiotepa—Cardiac disorder—Varenicline—nicotine dependence	0.0139	0.0142	CcSEcCtD
Thiotepa—Angiopathy—Varenicline—nicotine dependence	0.0136	0.0139	CcSEcCtD
Thiotepa—Immune system disorder—Varenicline—nicotine dependence	0.0135	0.0138	CcSEcCtD
Thiotepa—Mediastinal disorder—Varenicline—nicotine dependence	0.0135	0.0138	CcSEcCtD
Thiotepa—Chills—Varenicline—nicotine dependence	0.0134	0.0137	CcSEcCtD
Thiotepa—Arrhythmia—Varenicline—nicotine dependence	0.0134	0.0137	CcSEcCtD
Thiotepa—Mental disorder—Varenicline—nicotine dependence	0.0131	0.0134	CcSEcCtD
Thiotepa—Erythema—Varenicline—nicotine dependence	0.013	0.0133	CcSEcCtD
Thiotepa—Malnutrition—Varenicline—nicotine dependence	0.013	0.0133	CcSEcCtD
Thiotepa—Back pain—Varenicline—nicotine dependence	0.0126	0.0129	CcSEcCtD
Thiotepa—Vision blurred—Varenicline—nicotine dependence	0.0123	0.0125	CcSEcCtD
Thiotepa—Anaemia—Varenicline—nicotine dependence	0.012	0.0123	CcSEcCtD
Thiotepa—Agitation—Varenicline—nicotine dependence	0.012	0.0122	CcSEcCtD
Thiotepa—Cough—Varenicline—nicotine dependence	0.0114	0.0116	CcSEcCtD
Thiotepa—Convulsion—Varenicline—nicotine dependence	0.0113	0.0115	CcSEcCtD
Thiotepa—Hypertension—Varenicline—nicotine dependence	0.0112	0.0115	CcSEcCtD
Thiotepa—Arthralgia—Varenicline—nicotine dependence	0.0111	0.0113	CcSEcCtD
Thiotepa—Myalgia—Varenicline—nicotine dependence	0.0111	0.0113	CcSEcCtD
Thiotepa—Anxiety—Varenicline—nicotine dependence	0.011	0.0113	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.011	0.0112	CcSEcCtD
Thiotepa—Infection—Varenicline—nicotine dependence	0.0106	0.0108	CcSEcCtD
Thiotepa—Nervous system disorder—Varenicline—nicotine dependence	0.0104	0.0106	CcSEcCtD
Thiotepa—Thrombocytopenia—Varenicline—nicotine dependence	0.0104	0.0106	CcSEcCtD
Thiotepa—Tachycardia—Varenicline—nicotine dependence	0.0104	0.0106	CcSEcCtD
Thiotepa—Skin disorder—Varenicline—nicotine dependence	0.0103	0.0105	CcSEcCtD
Thiotepa—Anorexia—Varenicline—nicotine dependence	0.0101	0.0104	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00968	0.00989	CcSEcCtD
Thiotepa—Somnolence—Varenicline—nicotine dependence	0.00944	0.00965	CcSEcCtD
Thiotepa—Dyspepsia—Varenicline—nicotine dependence	0.00935	0.00956	CcSEcCtD
Thiotepa—Decreased appetite—Varenicline—nicotine dependence	0.00923	0.00944	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00917	0.00938	CcSEcCtD
Thiotepa—Fatigue—Varenicline—nicotine dependence	0.00916	0.00936	CcSEcCtD
Thiotepa—Pain—Varenicline—nicotine dependence	0.00908	0.00929	CcSEcCtD
Thiotepa—Constipation—Varenicline—nicotine dependence	0.00908	0.00929	CcSEcCtD
Thiotepa—Feeling abnormal—Varenicline—nicotine dependence	0.00875	0.00895	CcSEcCtD
Thiotepa—Gastrointestinal pain—Varenicline—nicotine dependence	0.00868	0.00888	CcSEcCtD
Thiotepa—Urticaria—Varenicline—nicotine dependence	0.00844	0.00863	CcSEcCtD
Thiotepa—Abdominal pain—Varenicline—nicotine dependence	0.0084	0.00858	CcSEcCtD
Thiotepa—Body temperature increased—Varenicline—nicotine dependence	0.0084	0.00858	CcSEcCtD
Thiotepa—Hypersensitivity—Varenicline—nicotine dependence	0.00782	0.008	CcSEcCtD
Thiotepa—Asthenia—Varenicline—nicotine dependence	0.00762	0.00779	CcSEcCtD
Thiotepa—Pruritus—Varenicline—nicotine dependence	0.00751	0.00768	CcSEcCtD
Thiotepa—Diarrhoea—Varenicline—nicotine dependence	0.00727	0.00743	CcSEcCtD
Thiotepa—Dizziness—Varenicline—nicotine dependence	0.00702	0.00718	CcSEcCtD
Thiotepa—Vomiting—Varenicline—nicotine dependence	0.00675	0.0069	CcSEcCtD
Thiotepa—Rash—Varenicline—nicotine dependence	0.0067	0.00685	CcSEcCtD
Thiotepa—Dermatitis—Varenicline—nicotine dependence	0.00669	0.00684	CcSEcCtD
Thiotepa—Headache—Varenicline—nicotine dependence	0.00665	0.0068	CcSEcCtD
Thiotepa—Nausea—Varenicline—nicotine dependence	0.00631	0.00645	CcSEcCtD
Thiotepa—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00519	0.235	CbGpPWpGaD
Thiotepa—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00405	0.184	CbGpPWpGaD
Thiotepa—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00322	0.146	CbGpPWpGaD
Thiotepa—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00146	0.0663	CbGpPWpGaD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00134	0.0606	CbGpPWpGaD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00132	0.0598	CbGpPWpGaD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00108	0.0491	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000611	0.0277	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000607	0.0275	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000599	0.0272	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000576	0.0261	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000568	0.0257	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000492	0.0223	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000278	0.0126	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000262	0.0119	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000258	0.0117	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP2A7—nicotine dependence	9.84e-05	0.00446	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2A7—nicotine dependence	4.47e-05	0.00203	CbGpPWpGaD
